Experiment: 6Q6E

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCA	0.4 mM [U-100% 13C; U-100% 15N;U-100% 2H] Ct Smc2 Brn1 fusion protein	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
2	3D HNCACB	0.4 mM [U-100% 13C; U-100% 15N;U-100% 2H] Ct Smc2 Brn1 fusion protein	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
3	3D HN(CO)CA	0.4 mM [U-100% 13C; U-100% 15N;U-100% 2H] Ct Smc2 Brn1 fusion protein	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
4	3D HN(COCA)CB	0.4 mM [U-100% 13C; U-100% 15N;U-100% 2H] Ct Smc2 Brn1 fusion protein	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
5	3D 1H-15N NOESY	0.8 mM [U-100% 13C; U-100% 15N] Ct Smc2 Brn1 fusion protein	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
6	3D 1H-13C NOESY aliphatic	0.8 mM [U-100% 13C; U-100% 15N] Ct Smc2 Brn1 fusion protein	90% H2O/10% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
8	3D 1H-13C NOESY aliphatic	0.6 mM [U-100% 13C; U-100% 15N] Ct Smc2 Brn1 fusion protein	100% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800
7	3D 1H-13C NOESY aromatic	0.6 mM [U-100% 13C; U-100% 15N] Ct Smc2 Brn1 fusion protein	100% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800
2	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CNS	1.2	Brunger A. T. et.al.
2	structure calculation	ARIA		Linge, O'Donoghue and Nilges
3	chemical shift assignment	NMRView		Johnson, One Moon Scientific
4	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	geometry optimization	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.